Table of Content

1. Introduction


2. Why is the US Generic Drug Market So Lucrative


3. Research & Methodology


4. Executive Summary


5. Market Dynamics

5.1 Growth Drivers
5.2 Challenges


6. Porter’s Five Forces Analysis- United States Generic Drugs Market

6.1 Bargaining Power of Buyers
6.2 Bargaining Power of Suppliers
6.3 Degree of Rivalry
6.4 Threat of New Entrants
6.5 Threat of Substitutes


7. SWOT Analysis- United States Generic Drugs Market

7.1 Strengths
7.2 Weaknesses
7.3 Opportunities
7.4 Threats


8. United States Generic Drugs Market


9. Market Share – United States Generic Drugs Analysis

9.1 By Type
9.2 By Therapeutic Area
9.3 By Drug Delivery
9.4 By Distribution Channel
9.5 By Age Group
9.6 By State
9.7 By Payment Type


10. Type- United States Generic Drugs Market

10.1 Branded Generics
10.2 Unbranded Generics


11. Therapeutic Area- United States Generic Drugs Market

11.1 Heart Disease
11.2 Mental Health
11.3 Diabetes
11.4 Epilepsy
11.5 Cancers
11.6 Allergies &Asthama
11.7 Chronic Obstructive Pulmonary Diesase
11.8 Alzheimer’s Disease
11.9 HIV/AIDS
11.10 Crohn’s colitis


12. Drug Delivery- United States Generic Drugs Market

12.1 Oral
12.2 Injectables
12.3 Dermal/Topical
12.4 Inhalers


13. Distribution Channel- United States Generic Drugs Market

13.1 Specialty Pharmacy
13.2 Retail Pharmacy
13.3 Hospital Pharmacy
13.4 Online Pharmacy


14. Age Group- United States Generic Drugs Market

14.1 Children (0-19 years)
14.2 Young Adults (20-39 years)
14.3 Adults (40-64 years)
14.4 Seniors (Above 65 years)


15. State- United States Generic Drugs Market

15.1 California
15.2 Texas
15.3 New York
15.4 Florida
15.5 Pennylavania
15.6 Ohio
15.7 Illionios
15.8 North Carolina
15.9 Georgia
15.10 Michigan
15.11 Others


16. Payment Type- United States Generic Drugs Market

16.1 Cash
16.2 Commercial
16.3 Medicaid
16.4 Medicare D


17. Frequency in consumption of Generic Drugs in United States

17.1 At least 1 prescription generic drugs consumption monthly

17.1.1 Male
17.1.2 Female

17.2 Three or more prescription generic drugs consumption monthly

17.2.1 Male
17.2.2 Female

17.3 Five or more Prescription generic drugs consumption monthly

17.3.1 Male
17.3.2 Female


18. US Generic Drug Market- Competitive Landscape

18.1 US Generic Drug Market - Competitive Structure
18.2 US Generic Drug Market - Breakup of Key Players
18.3 US Generic Drug Market - Most Prescribed Generic Drugs
18.4 US Generic Drug Market - Market Breakup by Distribution
18.5 US Generic Drug Market - Pricing Dynamics


19. Regulations in the US Generic Drug Industry

19.1 Overview of Pharmaceutical Regulations
19.2 Drug Applications
19.3 Patents and Market Exclusivity
19.4 Regulatory Requirements for Generic Drugs
19.5 The Hatch-Waxman Act
19.6 Certifications
19.7 Other Important Considerations


20. Key Players Analysis

20.1 Teva Pharmaceuticals

20.1.1 Overview
20.1.2 Sales Analysis
20.1.3 Recent Development

20.2 Aurobindo Pharma

20.2.1 Overview
20.2.2 Sales Analysis
20.2.3 Recent Development

20.3 Sun Pharmaceuticals

20.3.1 Overview
20.3.2 Sales Analysis
20.3.3 Recent Development

20.4 Abbott Laboratories Inc

20.4.1 Overview
20.4.2 Sales Analysis
20.4.3 Recent Development

20.5 Lupin Pharmaceuticals, Inc

20.5.1 Overview
20.5.2 Sales Analysis
20.5.3 Recent Development

20.6 Viatris

20.6.1 Overview
20.6.2 Sales Analysis
20.6.3 Recent Development

20.7 Sandoz

20.7.1 Overview
20.7.2 Sales Analysis
20.7.3 Recent Development

20.8 Dr. Reddy’s

20.8.1 Overview
20.8.2 Sales Analysis
20.8.3 Recent Development



List of Figures

Figure-01: United States – Generic Drugs Market (Billion US$), 2018 – 2022
Figure-02: United States – Forecast for Generic Drugs Market (Billion US$), 2023 – 2028
Figure-03: Type – Branded Generics Market (Billion US$), 2018 – 2022
Figure-04: Type – Forecast for Branded Generics Market (Billion US$), 2023 – 2028
Figure-05: Type – Unbranded Generics Market (Billion US$), 2018 – 2022
Figure-06: Type – Forecast for Unbranded Generics Market (Billion US$), 2023 – 2028
Figure-07: Therapeutic Area – Heart Disease Market (Billion US$), 2018 – 2022
Figure-08: Therapeutic Area – Forecast for Heart Disease Market (Billion US$), 2023 – 2028
Figure-09: Therapeutic Area – Mental Health Market (Billion US$), 2018 – 2022
Figure-10: Therapeutic Area – Forecast for Mental Health Market (Billion US$), 2023 – 2028
Figure-11: Therapeutic Area – Diabetes Market (Billion US$), 2018 – 2022
Figure-12: Therapeutic Area – Forecast for Diabetes Market (Billion US$), 2023 – 2028
Figure-13: Therapeutic Area – Epilepsy Market (Billion US$), 2018 – 2022
Figure-14: Therapeutic Area – Forecast for Epilepsy Market (Billion US$), 2023 – 2028
Figure-15: Therapeutic Area – Cancers Market (Billion US$), 2018 – 2022
Figure-16: Therapeutic Area – Forecast for Cancers Market (Billion US$), 2023 – 2028
Figure-17: Therapeutic Area – Allergies &Asthama Market (Billion US$), 2018 – 2022
Figure-18: Therapeutic Area – Forecast for Allergies &Asthama Market (Billion US$), 2023 – 2028
Figure-19: Therapeutic Area – Chronic Obstructive Pulmonary Diesase Market (Billion US$), 2018 – 2022
Figure-20: Therapeutic Area – Forecast for Chronic Obstructive Pulmonary Diesase Market (Billion US$), 2023 – 2028
Figure-21: Therapeutic Area – Alzheimer’s Disease Market (Billion US$), 2018 – 2022
Figure-22: Therapeutic Area – Forecast for Alzheimer’s Disease Market (Billion US$), 2023 – 2028
Figure-23: Therapeutic Area – HIV/AIDS Market (Billion US$), 2018 – 2022
Figure-24: Therapeutic Area – Forecast for HIV/AIDS Market (Billion US$), 2023 – 2028
Figure-25: Therapeutic Area – Crohn’s colitis Market (Billion US$), 2018 – 2022
Figure-26: Therapeutic Area – Forecast for Crohn’s colitis Market (Billion US$), 2023 – 2028
Figure-27: Drug Delivery – Oral Market (Billion US$), 2018 – 2022
Figure-28: Drug Delivery – Forecast for Oral Market (Billion US$), 2023 – 2028
Figure-29: Drug Delivery – Injectables Market (Billion US$), 2018 – 2022
Figure-30: Drug Delivery – Forecast for Injectables Market (Billion US$), 2023 – 2028
Figure-31: Drug Delivery – Dermal/Topical Market (Billion US$), 2018 – 2022
Figure-32: Drug Delivery – Forecast for Dermal/Topical Market (Billion US$), 2023 – 2028
Figure-33: Drug Delivery – Inhalers Market (Billion US$), 2018 – 2022
Figure-34: Drug Delivery – Forecast for Inhalers Market (Billion US$), 2023 – 2028
Figure-35: Distribution Channel – Specialty Pharmacy Market (Billion US$), 2018 – 2022
Figure-36: Distribution Channel – Forecast for Specialty Pharmacy Market (Billion US$), 2023 – 2028
Figure-37: Distribution Channel – Retail Pharmacy Market (Billion US$), 2018 – 2022
Figure-38: Distribution Channel – Forecast for Retail Pharmacy Market (Billion US$), 2023 – 2028
Figure-39: Distribution Channel – Hospital Pharmacy Market (Billion US$), 2018 – 2022
Figure-40: Distribution Channel – Forecast for Hospital Pharmacy Market (Billion US$), 2023 – 2028
Figure-41: Distribution Channel – Online Pharmacy Market (Billion US$), 2018 – 2022
Figure-42: Distribution Channel – Forecast for Online Pharmacy Market (Billion US$), 2023 – 2028
Figure-43: Age Group – Children (0-19 years) Market (Billion US$), 2018 – 2022
Figure-44: Age Group – Forecast for Children (0-19 years) Market (Billion US$), 2023 – 2028
Figure-45: Age Group – Young Adults (20-39 years) Market (Billion US$), 2018 – 2022
Figure-46: Age Group – Forecast for Young Adults (20-39 years) Market (Billion US$), 2023 – 2028
Figure-47: Age Group – Adults (40-64 years) Market (Billion US$), 2018 – 2022
Figure-48: Age Group – Forecast for Adults (40-64 years) Market (Billion US$), 2023 – 2028
Figure-49: Age Group – Seniors (Above 65 years) Market (Billion US$), 2018 – 2022
Figure-50: Age Group – Forecast for Seniors (Above 65 years) Market (Billion US$), 2023 – 2028
Figure-51: California – Generic Drugs Market (Billion US$), 2018 – 2022
Figure-52: California – Forecast for Generic Drugs Market (Billion US$), 2023 – 2028
Figure-53: Texas – Generic Drugs Market (Billion US$), 2018 – 2022
Figure-54: Texas – Forecast for Generic Drugs Market (Billion US$), 2023 – 2028
Figure-55: New York – Generic Drugs Market (Billion US$), 2018 – 2022
Figure-56: New York – Forecast for Generic Drugs Market (Billion US$), 2023 – 2028
Figure-57: Florida – Generic Drugs Market (Billion US$), 2018 – 2022
Figure-58: Florida – Forecast for Generic Drugs Market (Billion US$), 2023 – 2028
Figure-59: Pennylavania – Generic Drugs Market (Billion US$), 2018 – 2022
Figure-60: Pennylavania – Forecast for Generic Drugs Market (Billion US$), 2023 – 2028
Figure-61: Ohio – Generic Drugs Market (Billion US$), 2018 – 2022
Figure-62: Ohio – Forecast for Generic Drugs Market (Billion US$), 2023 – 2028
Figure-63: Illionios – Generic Drugs Market (Billion US$), 2018 – 2022
Figure-64: Illionios – Forecast for Generic Drugs Market (Billion US$), 2023 – 2028
Figure-65: North Carolina – Generic Drugs Market (Billion US$), 2018 – 2022
Figure-66: North Carolina – Forecast for Generic Drugs Market (Billion US$), 2023 – 2028
Figure-67: Georgia – Generic Drugs Market (Billion US$), 2018 – 2022
Figure-68: Georgia – Forecast for Generic Drugs Market (Billion US$), 2023 – 2028
Figure-69: Michigan – Generic Drugs Market (Billion US$), 2018 – 2022
Figure-70: Michigan – Forecast for Generic Drugs Market (Billion US$), 2023 – 2028
Figure-71: Others – Generic Drugs Market (Billion US$), 2018 – 2022
Figure-72: Others – Forecast for Generic Drugs Market (Billion US$), 2023 – 2028
Figure-73: Payment Type – Cash Market (Billion US$), 2018 – 2022
Figure-74: Payment Type – Forecast for Cash Market (Billion US$), 2023 – 2028
Figure-75: Payment Type – Commercial Market (Billion US$), 2018 – 2022
Figure-76: Payment Type – Forecast for Commercial Market (Billion US$), 2023 – 2028
Figure-77: Payment Type – Medicaid Market (Billion US$), 2018 – 2022
Figure-78: Payment Type – Forecast for Medicaid Market (Billion US$), 2023 – 2028
Figure-79: Payment Type – Medicare D Market (Billion US$), 2018 – 2022
Figure-80: Payment Type – Forecast for Medicare D Market (Billion US$), 2023 – 2028
Figure-81: Male – At least One prescription generic drugs consumption monthly Market (Frequency), 2018 – 2022
Figure-82: Male – Forecast for At least One prescription generic drugs consumption monthly Market (Frequency), 2023 – 2028
Figure-83: Female – At least One prescription generic drugs consumption monthly Market (Frequency), 2018 – 2022
Figure-84: Female – Forecast for At least One prescription generic drugs consumption monthly Market (Frequency), 2023 – 2028
Figure-85: Male – Three or more prescription generic drugs consumption monthly Market (Frequency), 2018 – 2022
Figure-86: Male – Forecast for Three or more prescription generic drugs consumption monthly Market (Frequency), 2023 – 2028
Figure-87: Female – Three or more prescription generic drugs consumption monthly Market (Frequency), 2018 – 2022
Figure-88: Female – Forecast for Three or more prescription generic drugs consumption monthly Market (Frequency), 2023 – 2028
Figure-89: Male – Five or more Prescription generic drugs consumption monthly Market (Frequency), 2018 – 2022
Figure-90: Male – Forecast for Five or more Prescription generic drugs consumption monthly Market (Frequency), 2023 – 2028
Figure-91: Female – Five or more Prescription generic drugs consumption monthly Market (Frequency), 2018 – 2022
Figure-92: Female – Forecast for Five or more Prescription generic drugs consumption monthly Market (Frequency), 2023 – 2028
Figure-93: Teva Pharmaceuticals – Global Revenue (Billion US$), 2018 – 2022
Figure-94: Teva Pharmaceuticals – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-95: AurobindoPharma – Global Revenue (Billion US$), 2018 – 2022
Figure-96: AurobindoPharma – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-97: Sun Pharmaceuticals – Global Revenue (Billion US$), 2018 – 2022
Figure-98: Sun Pharmaceuticals – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-99: Abbott Laboratories Inc – Global Revenue (Billion US$), 2018 – 2022
Figure-100: Abbott Laboratories Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-101: Lupin Pharmaceuticals, Inc – Global Revenue (Billion US$), 2018 – 2022
Figure-102: Lupin Pharmaceuticals, Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-103: Viatris – Global Revenue (Billion US$), 2018 – 2022
Figure-104: Viatris – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-105: Sandoz – Global Revenue (Billion US$), 2018 – 2022
Figure-106: Sandoz – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-107: Dr. Reddy’s – Global Revenue (Billion US$), 2018 – 2022
Figure-108: Dr. Reddy’s – Forecast for Global Revenue (Billion US$), 2023 – 2028

List of Tables

Table-01: United States – Generic Drugs Market Share by Type (Percent), 2018 – 2022
Table-02: United States – Forecast for Generic Drugs Market Share by Type (Percent), 2023 – 2028
Table-03: United States – Generic Drugs Market Share by Therapeutic Area (Percent), 2018 – 2022
Table-04: United States – Forecast for Generic Drugs Market Share by Therapeutic Area (Percent), 2023 – 2028
Table-05: United States – Generic Drugs Market Share by Drug Delivery (Percent), 2018 – 2022
Table-06: United States – Forecast for Generic Drugs Market Share by Drug Delivery (Percent), 2023 – 2028
Table-07: United States – Generic Drugs Market Share by Distribution Channel (Percent), 2018 – 2022
Table-08: United States – Forecast for Generic Drugs Market Share by Distribution Channel (Percent), 2023 – 2028
Table-09: United States – Generic Drugs Market Share by Age Group (Percent), 2018 – 2022
Table-10: United States – Forecast for Generic Drugs Market Share by Age Group (Percent), 2023 – 2028
Table-11: United States – Generic Drugs Market Share by State (Percent), 2018 – 2022
Table-12: United States – Forecast for Generic Drugs Market Share by State (Percent), 2023 – 2028
Table-13: United States – Generic Drugs Market Share by Payment Type (Percent), 2018 – 2022
Table-14: United States – Forecast for Generic Drugs Market Share by Payment Type (Percent), 2023 – 2028